Home › Funds › Redmile Group, LLC › SLN
Redmile Group, LLC position in SLN
SILENCE THERAPEUTICS PLC · Health Care
Redmile Group, LLC reported holding 2,164,777 shares of SLN (SILENCE THERAPEUTICS PLC) in its Q2 2026 13F filing — a position valued at US$23.8M, representing 1.60% of its reported portfolio and ranking #15 among its reported holdings. Redmile Group, LLC has disclosed SLN holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Redmile Group, LLC's SLN position evolved
Redmile Group, LLC first disclosed a stake in SLN in Q1 2024 at 2,027,669 shares (US$43.8M). Across 10 filings, Redmile Group, LLC increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 2,164,777 shares valued at US$23.8M. Notable position changes include a 26% increase in Q4 2024 (shares fell 59% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 2.03M | $43.80M | New |
| Q2 2024 | 2.01M | $38.27M | Reduce |
| Q3 2024 | 1.90M | $34.53M | Reduce |
| Q4 2024 | 2.40M | $16.51M | Add |
| Q1 2025 | 2.21M | $6.25M | Reduce |
| Q2 2025 | 2.16M | $12.56M | Reduce |
| Q3 2025 | 2.16M | $11.24M | Hold |
| Q4 2025 | 2.16M | $13.16M | Hold |
| Q1 2026 | 2.16M | $11.41M | Hold |
| Q2 2026 | 2.16M | $23.77M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SLN and 13F data
SLN (SILENCE THERAPEUTICS PLC) is a Health Care company. 35 other funds we track also report a position in SLN — the largest reported positions include Siren, L.L.C. (US$36.4M), TCG Crossover Management, LLC (US$33.3M), Nantahala Capital Management, LLC (US$14.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLN
- Siren, L.L.C. 3.31M sh · $36.36M · Q2 2026
- TCG Crossover Management, LLC 3.03M sh · $33.31M · Q2 2026
- Nantahala Capital Management, LLC 1.35M sh · $14.79M · Q2 2026
- Nextech Invest Ltd. 952.40K sh · $10.46M · Q2 2026
- 5AM Venture Management, LLC 476.20K sh · $5.23M · Q2 2026
- GREAT POINT PARTNERS LLC 450.00K sh · $4.94M · Q2 2026
- Tetragon Partners GP Ltd 300.00K sh · $3.29M · Q2 2026
- Ishara Investments LP 55.35K sh · $2.43M · Q2 2026
- Propel Bio Management, LLC 191.73K sh · $2.11M · Q2 2026
- M28 Capital Management LP 101.20K sh · $1.11M · Q2 2026
More on Redmile Group, LLC
FAQ
How long has Redmile Group, LLC held SLN?
Redmile Group, LLC has disclosed SLN holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is Redmile Group, LLC's current position in SLN?
As of Q2 2026, Redmile Group, LLC holds 2.16M shares of SLN (SILENCE THERAPEUTICS PLC), valued at $23.77M, representing 1.60% of its reported portfolio and ranking #15.
Has Redmile Group, LLC been buying or selling SLN?
In the latest 13F filing (Q2 2026), Redmile Group, LLC held unchanged its position in SLN.
Which other funds hold SLN?
Other major institutional holders of SLN include Siren, L.L.C., TCG Crossover Management, LLC, Nantahala Capital Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.